Research progress on immune function status and individualized treatment of elder patients with severe pneumonia

doi:10.3877/cma.j.issn.2095-8757.2019.04.009

Abstract

Abstract:

In recent years, the infection of drug-resistant bacteria in elder patients is gradually increasing. When they suffer from severe pneumonia, simply replacing anti-infective drugs may not be enough to improve the outcome and prognosis of the disease. Many studies have found that in the elderly with severe pneumonia, the body is prone to immune imbalance and progresses to immunosuppression, which is one of the important factors leading to the death of elder patients. Therefore, monitoring the changes of immune function indicators and biomarker in real time and observing the relationship between immune function status and the development of severe pulmonary infection dynamically, and giving effective individualized interventions based on these have great clinical significance in the treatment and prognosis of severe pneumonia in the elderly.

Key words: Severe pneumonia in the elderly, Immune status monitoring, Immunosuppression, Immunotherapy

Miaomiao Kong, Juan Yang, Muyun Zhu. Research progress on immune function status and individualized treatment of elder patients with severe pneumonia[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2019, 06(04): 40-44.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlnbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8757.2019.04.009

https://zhlnbyjdzzz.cma-cmc.com.cn/EN/Y2019/V06/I04/40

References 35

[12]	Yu ZX, Ji MS, Yan J, et al. The ratio of Th17/Treg cells as a risk indicator in early acute respiratory distress syndrome[J].Crit Care, 2015, 19: 82.
[13]	陈坤，周秋香，单红卫，等．CD4⁺CD25⁺调节性T细胞在脓毒症预后评价中的应用[J]．中华急诊医学杂志，2015，24(1)：72-76
[14]	Zhao GJ, Li D, Zhao Q, et al. Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study[J]. Sci Rep, 2016, 6:38361.
[15]	Sun N, Wei X, Wang J, et al. Caveolin-1 promotes the imbalance of Th17/Treg in patients with chronic obstructive pulmonary disease[J]. Inflammation, 2016, 39(6):2008-2015.
[16]	吴铁军，张丽娜，亢翠翠.Treg/Th17失衡在脓毒症发病机制中的作用[J].中国病理生理杂志，2011，27(12)：2411-2413.
[17]	Liu Q, Zheng H, Chen X, et al. Human mesenchymal stromal cells enhance the immunomodulatory function of CD8⁺CD28^-regulatory T cells[J].Cell Mol Immunol, 2015, 12(6):708-718.
[18]	麦惠强，许进，蓝先旗，等.多发伤患者CD8⁺CD28^-T细胞含量变化及其临床意义[J].南方医科大学学报，2016，36(4)：544-547.
[19]	Chinai JM, Janakiram M, Chen F, et al. New immunotherapies targeting the PD-1 pathway[J]. Trends Pharmacol Sci, 2015, 36(9):587-595.
[20]	袁洁铭，李理，袁伟锋，等.老年人T淋巴细胞PD-1高表达在炎症状态下对其功能的影响[J].免疫学杂志，2017，33(6)：519-524.
[21]	Kahn JM, Le T, Angus DC, et al. The epidemiology of chronic critical illness in The United States[J]. Crit Care Med, 2015, 43(2):282-287.
[22]	Baertling F, Meissner T, Tmeger A, et al. Granulocyte colony stimulating factor for treatment of neutmpenia-associated infection in Pearson syndrome[J]. Klin Padiatr, 2014, 226(3):190-191.
[23]	Bo L, Wang F, Zhu J, et al. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulaTing factor (GM-CSF) for sepsis: a meta-analysis[J]. Crit Care, 2011, 15(1):R58.
[24]	Mayer CT, Ghorbani P, Nandan A, et al. Selective and efficient generation of functional Batf3-dependent CD103⁺dendritic cells from mouse bone marrow[J]. Blood, 2014, 124(20):3081.
[25]	Xu Q, Zhu YF, Wang HC, et al. Enhanced efficacy of DNA vaccination against botulinum neurotoxin serotype A by co-administration of plasmids encoding DC-sTimulaTing FlT3L and MIP-3α cytokines[J].Biologicals, 2016, 44(5):441-447.
[26]	Pica F, ChimenTi MS, Gaziano R, et al. Serum thymosin alpha 1 levels in patients with chronic inflammatory autoimmune diseases[J]. Clin Experiment Immunol, 2016, 186(1):39-45.
[27]	Garaci E, Pica F, Matteucci C, et a1. Historical review on thymosin alphal in oncology: preclinical and clinical experiences[J]. Expert Opin Biol Ther, 2015, 15 Suppl 1:S31-S39.
[28]	Yang X, Qian F, He HY, et al. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro[J]. Braz J Med Biol Res, 2012, 45(1):25-32.
[29]	Patera AC, Drewry AM, Chang K, et al. Frontline science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1[J]. J Leukoc Biol, 2016, 100(6):1239-1254.
[30]	Zhang Y, Zhou Y, Lou J, et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction[J]. Crit Care, 2010, 14(6):R220.
[31]	Shindo Y, Fuchs AG, Davis CG, et al. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of pseudomonas aeruginosa pneumonia[J]. J Leukoc Biol, 2017, 101(2): 543-554.
[32]	Demaret J, et al. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study[J]. J Leukoc Biol, 2015, 97(4):791-796.
[33]	Shindo Y, McDonough JS, Chang KC, et al. Anti-PD-L1 peptide improves survival in sepsis[J]. J Surg Res, 2017, 208:33-39.
[34]	Francois B, JeanneT R, Daix T, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial[J]. JCI Insight, 2018, 3(5). doi: 10.1172/jci.insight.98960.
[35]	高铭鑫，李海涛，张帆，等.肺灌注抗肿瘤坏死因子抗体对体外循环肺超微结构的影响[J].中华胸心血管外科杂志，2016，30(1)：33-37.
[1]	中国医师协会急诊医师分会.中国急诊重症肺炎临床实践专家共识[J/CD].中国急救医学，2016，36(2)：97-107.
[2]	Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care [J]. J Trauma Acute Care Surg, 2012, 72(6):1491-1501.
[3]	Su HY, Mo ZX, Chen Z, et al. Severe disease of immune imbalance in ICU: persistent flammation immunosuppression catabolism syndrome[J]. Chin Crit Care Med, 2017, 29 (8):760-764.
[4]	Wang JF, Li JB, Zhao YJ, et al. Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study[J]. Anesthesiology, 2015, 122(4):852-863.
[5]	Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management[J]. BMJ, 2016, 353:i1585.
[6]	Lee J, Tam H, Adler L, et al. The MHC classⅡantigenpresentation pathway in human monocytes differs by subset and is regulated by cytokines[J]. PloS one, 2017, 12(8):e0183594.
[7]	魏莉，白洁，王丽，等.免疫治疗对重症肺炎患者免疫功能指标的影响研究[J].中华医院感染学杂志，2014，24(12)：2871-2873.
[8]	Grailer JJ, Kalbitz M, Zetoune FS, et al. Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis[J].J Innate Immun, 2014, 6(5):695-705.
[9]	刘军.危重病免疫功能监测研究进展[J].中华重症医学电子杂志(网络版)，2019，5(1)：56-63.
[10]	程静，姚晔，谢丛华.放射性肺损伤与Th1/Th2免疫失衡研究进展[J].中华放射肿瘤学杂志，2017，26(6)：706-710.
[11]	解立新，肖坤.免疫失衡是重症感染的核心问题之一[J].中华结核和呼吸杂志，2018，4(9)：675-677.

Please choose a citation manager

Content to export